Lucid Diagnostics Inc. (LUCD)

Nasdaq: LUCD · Surgical & Medical Instruments & Apparatus · New York, NY · filing with the SEC since 2020

Full chart Alerts Compare

Grade3.4

◀ Past 3.5● Present 2.5▶ Future 4.3

4 est.

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

The grade of Lucid Diagnostics Inc.

Nine metrics read from its own filings, by tense

Headline grade

3.4/10

◀ Past3.530% of the headline

● Present2.540% of the headline

▶ Future4.330% of the headline

All three tenses have at least two readings, so the archetype blend applies as printed.

Of the nine metrics, 5 read as filed from the record and 4 are SI estimates, each with its reasoning, its confidence and what would change it on its card.

◀ Past

What did they actually do?

3.5/1030% of the headline grade · 1 of 3 filed, 2 estimated

Surviving crises

as filed

1.9/10

Has it survived what it has been through?

6 warning events since 2020; the latest 2026-10-16.

weight 33% of this tense · 19th percentile among 121 sector filers · read for itself

From the record

Lucid Diagnostics Inc.'s filings since 2020 show 6 warning events of 3 kinds: a notice about its exchange listing (8-K item 3.01, 4 times, the latest 2026-10-16); an auditor change (8-K item 4.01, the latest 2025-04-25); a late-report notice (Form NT 10-K or NT 10-Q, the latest 2022-04-01) (its current reports).

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Track record

SI estimate

5.1/10

What has it actually done, year after year?

SI estimate 5.1/10, confidence 20 of 100 (family median).

weight 45% of this tense · 50th percentile among 105 sector filers · read for its customers

SI estimate Inferred, not read as filed

Why it is an estimate: Fewer than three filed years of revenue on file, so the desk assumes the typical reading of its industry family, the median of 105 members with one.
What the record cannot read: Fewer than three filed years of revenue on file.
How it was reasoned: family median, 105 readings behind it.
Confidence: 20 of 100
What would change it: Its next annual report on file with the inputs replaces this estimate with the filed reading.

From the record

SI estimate, not a filed reading: Lucid Diagnostics Inc.'s track record is put at 5.1 of 10 with a confidence of 20 of 100, because fewer than three filed years of revenue on file, so the desk assumes the typical reading of its industry family, the median of 105 members with one. Its next annual report on file with the inputs replaces this estimate with the filed reading.

Shareholder treatment

SI estimate

2.8/10

How has it treated the people who own it?

SI estimate 2.8/10, confidence 35 of 100 (one part).

weight 22% of this tense · 28th percentile among 120 sector filers · read for its shareholders

SI estimate Inferred, not read as filed

Why it is an estimate: Read from one part only, the share count over the years, which ranks in the bottom 28% of 120 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income.
What the record cannot read: Fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income.
How it was reasoned: one part: the share count over the years, the one part on file, ranked among 120 in its family.
Confidence: 35 of 100
What would change it: A filing that carries the missing parts replaces this estimate with the filed reading.

From the record

SI estimate, not a filed reading: Lucid Diagnostics Inc.'s shareholder treatment is put at 2.8 of 10 with a confidence of 35 of 100, because read from one part only, the share count over the years, which ranks in the bottom 28% of 120 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income. A filing that carries the missing parts replaces this estimate with the filed reading.

● Present

What are they doing right now?

2.5/1040% of the headline grade · 3 of 3 filed

Financial health

as filed

1.3/10

Is it financially healthy right now?

ROE -530%: lost 530¢ per shareholder dollar. Leverage 73%: owes 73¢ per asset dollar.

weight 45% of this tense · 13th percentile among 120 sector filers · read for itself

From the record

Return on equity: in the fiscal year ended 2025-12-31, Lucid Diagnostics Inc. lost about 530 cents for every dollar of shareholders' money, and gross profitability: its products earned less than nothing, about minus 5 cents per dollar of everything the company owns (revenue less the cost of revenue). Leverage: it owed about 73 cents per dollar of assets, and net share issuance: its share count grew 101.8% over the year (the filed statements).

What it rests on

what it owes per dollar of assetsbottom 21% of its family
return on equitybottom 8% of its family
gross profit against assetsbottom 1% of its family
the share count against the year beforebottom 22% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Industry position

as filed

2.1/10

How strong is its position in its industry?

bottom 21% of 109 in its family; net margin -1232.7%.

weight 33% of this tense · 21st percentile among 109 sector filers · read for its customers

From the record

Lucid Diagnostics Inc.'s standing among 109 graded names in its industry family: revenue of $5 million in fiscal 2025 ranks in the bottom 17% by size; a net margin of -1232.7% ranks in the bottom 8%; revenue growth of 8.3% a year over the last 1 filed years ranks in the bottom 39% (its annual reports).

What it rests on

revenue against the family$4.7Mbottom 17% of its family
net margin-1232.7%bottom 8% of its family
three-year revenue growth8.3%bottom 39% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Leadership

as filed

5.7/10

What are the people in charge doing?

top 43% of 91 in its family for leadership; chief executive since 2021.

weight 22% of this tense · 57th percentile among 91 sector filers · read for its shareholders

From the record

Lucid Diagnostics Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Aklog, Lishan (Chief Executive Officer, as filed), filing under that title since 2021-10-13, 5.1 years (top 50% of its family); the 12 officers and directors filing in the last fifteen months have been on the record a median of 4.8 years (bottom 37%); 3 officer or director changes were reported on Form 8-K since 2023-11-13, against the 12 people in charge now (top 17%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

What it rests on

officer and director changes on Form 8-K, against the people in charge3 in three years among 12 peopletop 17% of its family
the median years the people in charge have filed4.8 yearsbottom 37% of its family
the chief executive's years on the record5.1 yearstop 50% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

▶ Future

What are they set up to do next?

4.3/1030% of the headline grade · 1 of 3 filed, 2 estimated

Room to expand

as filed

3.2/10

How much room does it have to grow?

bottom 32% of 104 in its family for room to expand.

weight 45% of this tense · 32nd percentile among 104 sector filers · read for itself

From the record

Lucid Diagnostics Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash from operations less capital spending is -992% of revenue (bottom 7%); a gross margin of -41.7% (bottom 3%); research spending of 120.7% of revenue (top 14%) (its annual report).

What it rests on

cash from operations less capital spending against revenue-992.0%bottom 7% of its family
gross margin-41.7%bottom 3% of its family
research spending against revenue120.7%top 14% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Growth drivers

SI estimate

5.2/10

What could actually drive growth from here?

SI estimate 5.2/10, confidence 20 of 100 (family median).

weight 33% of this tense · 50th percentile among 105 sector filers · read for its customers

SI estimate Inferred, not read as filed

Why it is an estimate: The record does not carry three filed years of revenue and two of the four parts: acceleration, the newest year's growth, the growth of research and of capital spending, so the desk assumes the typical reading of its industry family, the median of 105 members with one.
What the record cannot read: The record does not carry three filed years of revenue and two of the four parts: acceleration, the newest year's growth, the growth of research and of capital spending.
How it was reasoned: family median, 105 readings behind it.
Confidence: 20 of 100
What would change it: Its next annual report on file with the inputs replaces this estimate with the filed reading.

From the record

SI estimate, not a filed reading: Lucid Diagnostics Inc.'s growth drivers is put at 5.2 of 10 with a confidence of 20 of 100, because the record does not carry three filed years of revenue and two of the four parts: acceleration, the newest year's growth, the growth of research and of capital spending, so the desk assumes the typical reading of its industry family, the median of 105 members with one. Its next annual report on file with the inputs replaces this estimate with the filed reading.

Expectations vs reality

SI estimate

5.1/10

Did its newest year beat what its own record pointed to?

SI estimate 5.1/10, confidence 20 of 100 (family median).

weight 22% of this tense · 50th percentile among 88 sector filers · read for its shareholders

SI estimate Inferred, not read as filed

Why it is an estimate: The record does not carry four filed years of revenue and two of the three parts: revenue against the prior pace, earnings against the prior average, the margin change, so the desk assumes the typical reading of its industry family, the median of 88 members with one.
What the record cannot read: The record does not carry four filed years of revenue and two of the three parts: revenue against the prior pace, earnings against the prior average, the margin change.
How it was reasoned: family median, 88 readings behind it.
Confidence: 20 of 100
What would change it: Its next annual report on file with the inputs replaces this estimate with the filed reading.

From the record

SI estimate, not a filed reading: Lucid Diagnostics Inc.'s expectations vs reality is put at 5.1 of 10 with a confidence of 20 of 100, because the record does not carry four filed years of revenue and two of the three parts: revenue against the prior pace, earnings against the prior average, the margin change, so the desk assumes the typical reading of its industry family, the median of 88 members with one. Its next annual report on file with the inputs replaces this estimate with the filed reading.

The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made

SI Assistanton LUCD · research, not advice